DoseMate is a health-tracking app for GLP-1 medication users on iOS, designed to log injections and monitor metabolic health metrics.
The App DNA
What makes this app unique?
Patients use DoseMate to correlate medication timing with weight and glucose trends, removing the cognitive load of manual health logging.
For Individuals prescribed GLP-1 medications who need to monitor weight loss, blood glucose, and side effects.
What does it look like?
Key features
Logs injection history for specific medications; drives daily active usage through habit-forming logging.
Automates data import for weight and glucose; reduces manual entry friction to improve long-term retention.
Monitors intake versus expenditure; creates a recurring engagement loop for goal-oriented users.
How much does it cost?
DoseMate is currently free with no visible IAP or subscription gates, limiting its ability to fund ongoing development.
Velocity
Dormant developmentopaqueShow more...
DoseMate - GLP-1 Tracker has been inactive for 293 days, falling well outside the threshold for active development. The only release in the observed window was a minor update focused on bug fixes. Given the lack of updates for nearly ten months, the app is currently in a zombie state with no evidence of ongoing feature development or maintenance.
Who built it?
Qianfan Hong Kong
3 apps tracked · Health & Fitness
OnSpace AI:Mobile App Builder
Crushie Al: Romance AI ChatUser Sentiment
What do users think recently?
Fresh user feedback skews excited. Users appreciate health data integration with apple health provides a convenient way to track wellness metrics alongside medication and simple and accurate tracking tools help users maintain consistency with their medication and health goals.
How are ratings & reviews evolving?
What users say, by theme
- Health data integration with Apple Health provides a convenient way to track wellness metrics alongside medication
- Simple and accurate tracking tools help users maintain consistency with their medication and health goals
3 of 3 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for DoseMate - GLP-1 Tracker
How's the Health & Fitness market?
DoseMate occupies a niche health-tracking segment with a 3-star rating across 16 total platform ratings. The absence of monetization and a 9-month update gap suggest the app is currently in a maintenance-only posture.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for DoseMate - GLP-1 Tracker
Where is it heading?
The health-tracking market is consolidating around apps that offer deep integration and frequent feature updates. DoseMate is currently exposed due to its stalled development, and it must pivot to a sustainable monetization model to fund the feature expansion users demand.
- The 9-month update gap signals a maintenance-mode posture, which prevents the app from addressing critical user requests for dosage flexibility.
- Positive sentiment regarding Apple Health integration suggests the core value proposition remains relevant to this app GLP-1 user base.
The SWOT
- Apple Health integration reduces user effort
- Tiered premium features for advanced analytics
Next best moves
Ship manual dosage input because users request flexibility for peptide tracking → improve retention
The counter-intuitive read
The lack of monetization is a strategic risk: without revenue…
Read the full takeBottom line
Expanding dosage input flexibility would address the primary user request and stabilize the current retention loop. If DoseMate remains in maintenance mode, the lack of feature evolution will likely lead to churn as users migrate to more frequently updated health trackers.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated